P187托珠单抗在SARS-CoV-2疾病中的临床结局和治疗相关不良事件

Fighting back: optimising treatment for COVID-19 Pub Date : 2021-11-01 DOI:10.1136/thorax-2021-btsabstracts.296

S. Ahmad, E. Jenkinson, R. Carney, T. Nahu, J. Quinn, A. Dwarakanath

{"title":"P187托珠单抗在SARS-CoV-2疾病中的临床结局和治疗相关不良事件","authors":"S. Ahmad, E. Jenkinson, R. Carney, T. Nahu, J. Quinn, A. Dwarakanath","doi":"10.1136/thorax-2021-btsabstracts.296","DOIUrl":null,"url":null,"abstract":"P187 Figure 1Showing the post Tocilizumab alert card[Figure omitted. See PDF]ConclusionAppropriate treatment protocol and regular monitoring are needed for patients who receive Tocilizumab in severe SARS-CoV-2 illness. Clinicians should bear in mind the high incidence of treatment-related adverse events and the lack of data about long term effects. Treatment alert cards and specific discharge advice may be beneficial.","PeriodicalId":143926,"journal":{"name":"Fighting back: optimising treatment for COVID-19","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"P187 Clinical outcomes and treatment-related adverse events to tocilizumab in SARS-CoV-2 illness\",\"authors\":\"S. Ahmad, E. Jenkinson, R. Carney, T. Nahu, J. Quinn, A. Dwarakanath\",\"doi\":\"10.1136/thorax-2021-btsabstracts.296\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"P187 Figure 1Showing the post Tocilizumab alert card[Figure omitted. See PDF]ConclusionAppropriate treatment protocol and regular monitoring are needed for patients who receive Tocilizumab in severe SARS-CoV-2 illness. Clinicians should bear in mind the high incidence of treatment-related adverse events and the lack of data about long term effects. Treatment alert cards and specific discharge advice may be beneficial.\",\"PeriodicalId\":143926,\"journal\":{\"name\":\"Fighting back: optimising treatment for COVID-19\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Fighting back: optimising treatment for COVID-19\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/thorax-2021-btsabstracts.296\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fighting back: optimising treatment for COVID-19","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/thorax-2021-btsabstracts.296","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

P187图1显示托珠单抗后警示卡[图略]。结论重症SARS-CoV-2患者接受托珠单抗治疗需要合理的治疗方案和定期监测。临床医生应牢记治疗相关不良事件的高发生率和缺乏长期影响的数据。治疗警报卡和具体的出院建议可能是有益的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

P187 Clinical outcomes and treatment-related adverse events to tocilizumab in SARS-CoV-2 illness

P187 Figure 1Showing the post Tocilizumab alert card[Figure omitted. See PDF]ConclusionAppropriate treatment protocol and regular monitoring are needed for patients who receive Tocilizumab in severe SARS-CoV-2 illness. Clinicians should bear in mind the high incidence of treatment-related adverse events and the lack of data about long term effects. Treatment alert cards and specific discharge advice may be beneficial.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Fighting back: optimising treatment for COVID-19

自引率

0.00%

发文量